Literature DB >> 6852916

Lysosomal response of a murine macrophage-like cell line persistently infected with Coxiella burnetii.

E T Akporiaye, J D Rowatt, A A Aragon, O G Baca.   

Abstract

The lysosomal response of a murine macrophage-like tumor cell line (J774) during persistent infection with Coxiella burnettii was examined. By using acid phosphatase as a lysosomal marker, it was shown that phagosome-lysosome fusion occurred in J774 cells persistently infected with C. burnetii. This observation was verified using thorium dioxide, an electron-dense compound that is sequestered in secondary lysosomes. The phagolysosomes contained viable replicating rickettsiae. Spectrofluorometric analysis indicated that the phagolysosomal pH of persistently infected cells was acidic. In attempts to correlate rickettsial survival with lysosome function, the activities of several lysosomal enzymes were assayed in both infected and uninfected cells. Activities of acid phosphatase and beta-acetylglucosaminidase were not significantly altered during infection. However, infected cells appeared to display slightly higher intracellular lysozyme, beta-glucuronidase, and beta-galactosidase activities.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6852916      PMCID: PMC348171          DOI: 10.1128/iai.40.3.1155-1162.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents.

Authors:  S Ohkuma; B Poole
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

Review 2.  Biochemical criteria for activated macrophages.

Authors:  M L Karnovsky; J K Lazdins
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

3.  Electron microscopic studies of the rickettsia Coxiella burneti: entry, lysosomal response, and fate of rickettsial DNA in L-cells.

Authors:  P R Burton; N Kordová; D Paretsky
Journal:  Can J Microbiol       Date:  1971-02       Impact factor: 2.419

4.  Method for counting Rickettsiae and Chlamydiae in purified suspensions.

Authors:  R Silberman; P Fiset
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

5.  The development of Trypanosoma cruzi in macrophages in vitro. Interaction with lysosomes and host cell fate.

Authors:  R Milder; J Kloetzel
Journal:  Parasitology       Date:  1980-02       Impact factor: 3.234

6.  Fate of phase I and phase II Coxiella burnetii in several macrophage-like tumor cell lines.

Authors:  O G Baca; E T Akporiaye; A S Aragon; I L Martinez; M V Robles; N L Warner
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

7.  Phagosome-lysosome fusion. Characterization of intracellular membrane fusion in mouse macrophages.

Authors:  M C Kielian; Z A Cohn
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

8.  Lysosomes in skeletal muscle tissue. Zonal centrifugation evidence for multiple cellular sources.

Authors:  P G Canonico; J W Bird
Journal:  J Cell Biol       Date:  1970-05       Impact factor: 10.539

9.  Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival.

Authors:  J A Armstrong; P D Hart
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

10.  In vitro induction of lysosomal enzymes by phagocytosis.

Authors:  S G Axline; Z A Cohn
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

View more
  60 in total

1.  Coxiella burnetii exhibits morphological change and delays phagolysosomal fusion after internalization by J774A.1 cells.

Authors:  D Howe; L P Mallavia
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 2.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

3.  A Coxiella burnetti repeated DNA element resembling a bacterial insertion sequence.

Authors:  T A Hoover; M H Vodkin; J C Williams
Journal:  J Bacteriol       Date:  1992-09       Impact factor: 3.490

4.  Phagolysosomes of Coxiella burnetii-infected cell lines maintain an acidic pH during persistent infection.

Authors:  M Maurin; A M Benoliel; P Bongrand; D Raoult
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

5.  Coxiella burnetii alters cyclic AMP-dependent protein kinase signaling during growth in macrophages.

Authors:  Laura J MacDonald; Richard C Kurten; Daniel E Voth
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

6.  Coxiella burnetii phase I and II variants replicate with similar kinetics in degradative phagolysosome-like compartments of human macrophages.

Authors:  Dale Howe; Jeffrey G Shannon; Seth Winfree; David W Dorward; Robert A Heinzen
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

7.  Coxiella burnetii type IVB secretion system region I genes are expressed early during the infection of host cells.

Authors:  John K Morgan; Brandon E Luedtke; Herbert A Thompson; Edward I Shaw
Journal:  FEMS Microbiol Lett       Date:  2010-08-18       Impact factor: 2.742

8.  Endosymbionts of ticks and their relationship to Wolbachia spp. and tick-borne pathogens of humans and animals.

Authors:  H Noda; U G Munderloh; T J Kurtti
Journal:  Appl Environ Microbiol       Date:  1997-10       Impact factor: 4.792

9.  Entry and survival of Leishmania amazonensis amastigotes within phagolysosome-like vacuoles that shelter Coxiella burnetii in Chinese hamster ovary cells.

Authors:  P S Veras; C Moulia; C Dauguet; C T Tunis; M Thibon; M Rabinovitch
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.